AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2012
Sep 5, 2012
30826_dirs_2012-09-04_f223b9e5-4f9e-4b22-883a-9ea48a47b6d4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2012-08-31
Reporting Person: Kelly William J (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-31 | Common Stock | M | 80000 | $4.82 | Acquired | 85000 | Direct |
| 2012-08-31 | Common Stock | M | 10000 | $3.33 | Acquired | 95000 | Direct |
| 2012-08-31 | Common Stock | S | 40409 | $5.50 | Disposed | 54591 | Direct |
| 2012-08-31 | Common Stock | S | 8500 | $5.51 | Disposed | 46091 | Direct |
| 2012-08-31 | Common Stock | S | 10700 | $5.52 | Disposed | 35391 | Direct |
| 2012-08-31 | Common Stock | S | 9681 | $5.53 | Disposed | 25710 | Direct |
| 2012-08-31 | Common Stock | S | 8000 | $5.54 | Disposed | 17710 | Direct |
| 2012-08-31 | Common Stock | S | 9900 | $5.55 | Disposed | 7810 | Direct |
| 2012-08-31 | Common Stock | S | 4803 | $5.56 | Disposed | 3007 | Direct |
| 2012-08-31 | Common Stock | S | 800 | $5.57 | Disposed | 2207 | Direct |
| 2012-08-31 | Common Stock | S | 1500 | $5.59 | Disposed | 707 | Direct |
| 2012-08-31 | Common Stock | S | 400 | $5.60 | Disposed | 307 | Direct |
| 2012-08-31 | Common Stock | S | 100 | $5.61 | Disposed | 207 | Direct |
| 2012-08-31 | Common Stock | S | 107 | $5.62 | Disposed | 100 | Direct |
| 2012-08-31 | Common Stock | S | 100 | $5.63 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-31 | Stock Option (Right to Buy) | $4.82 | M | 80000 | Disposed | 2018-03-31 | Common Stock (80000) | Direct |
| 2012-08-31 | Stock Option (Right to Buy) | $3.33 | M | 10000 | Disposed | 2020-07-15 | Common Stock (10000) | Direct |
Footnotes
F1: 20,000 shares vested and became exercisable at each of the following dates: 3/31/2009, 3/31/2010, 3/31/2011 and 3/31/2012.
F2: 5,000 shares each vested and became exercisable at 7/15/2011 and 7/15/2012.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23